TRAMs for Neuro-Oncological Decision-Making

February 7, 2017


Elements TRAMs (Treatment Response Assessment Maps) supports clinicians in differentiating tumor progression from treatment effects, such as radiation necrosis. The novel MRI-based methodology utilizes two acquisitions of standard T1-weighted MRI taken after injection of a contrast agent at both 5 minutes and 60 – 105 minutes. The first series is intelligently subtracted from the second to show the differentiation between contrast clearance and accumulation, the TRAMs. This makes Elements TRAMs an essential tool for neurosurgeons, radiation oncologists and tumor boards to distinguish between tumor and treatment effects.

To learn more, watch the video to see how clinicians use TRAMs for neuro-oncological decision-making.